September 9, 2019 — iCAD Inc. announced MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, selected the ProFound AI platform as the winner of its “Best New Radiology Solution” award in the 2019 MedTech Breakthrough Awards program.
ProFound AI for Digital Breast Tomosynthesis (DBT) is the first and only U.S. Food and Drug Administration (FDA)-cleared artificial intelligence (AI) solution that supports breast cancer detection in DBT, or 3-D mammography. The technology is intended to be used concurrently by radiologists reading DBT exams and uses a cutting-edge algorithm developed with the latest in deep learning.
Trained to detect malignant soft-tissue densities and calcifications, ProFound AI aids radiologists in breast cancer detection and is clinically proven to improve cancer detection rates, reduce false positives and unnecessary patient recalls, and decrease reading times for radiologists. The software rapidly and accurately analyzes each DBT image and provides radiologists with key information, such as Certainty of Finding and Case Scores, which assist radiologists in making clinical decisions and prioritizing caseloads.
The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories; this includes robotics, clinical administration, telehealth, patient engagement, electronic health records (EHR), mHealth and medical devices. This year’s program attracted more than 3,500 nominations from more than 15 different countries throughout the world.
“iCAD is a previous MedTech Breakthrough Award winner, and we are delighted to see the company continue to innovate. ProFound AI is a revolutionary technology built on the latest deep-learning and artificial intelligence technology that assists radiologists and addresses the challenges of reading breast tomosynthesis cases,” said James Johnson, managing director, MedTech Breakthrough. “We extend a hearty congratulations to the entire iCAD team on their innovative spirit and ability to execute on incorporating sophisticated AI technology in a platform that delivers incredibly real-world benefits.”
ProFound AI for DBT runs on the PowerLook platform with NVIDIA graphical processing units (GPU). PowerLook is a flexible and reliable DICOM platform that easily integrates with image modalities, mammography review workstations, picture archiving and communication systems (PACS) and image storage systems. Leveraging the latest in GPU technology, the algorithm can rapidly process a four-view tomosynthesis case, ensuring results are available to radiologists in the most efficient manner. Currently, ProFound AI for DBT is available for use with DBT systems in Europe, Canada and the United States.
For more information: www.icadmed.com
August 29, 2024 
